Key result
Bone marrow stem cells plus CABG improve LVEF by ~4% vs. CABG alone.
Why the study?
The effectiveness of delivering bone marrow mononuclear cells through graft vessels combined with CABG to improve left ventricular dyssynchrony in patients with previous myocardial infarction and chronic heart failure was investigated.
Meta-Analysis (n=914)
Supports adjunctive bone marrow stem cell delivery with CABG in ischemic heart disease; extends randomized evidence for LVEF gains.
OBJECTIVES: Several trials are investigating the delivery of stem cells to treat ischemic cardiomyopathy. The aim of this study was the echocardiographic evaluation of the effectiveness of isolated coronary artery bypass graft (CABG) combined with bone marrow mononuclear cells (BMMNC) delivered through the graft vessels to improve left ventricular dyssynchrony in patients with previous myocardial infarction and chronic heart failure. METHODS: 42 patients with previous myocardial infarction and chronic heart failure were randomly allocated to either the CABG only group (n = 18) or the CABG with BMMNC graft group (n = 24group). We used 2D strain imaging to measure the absolute difference in time-to-peak radial strain between the earliest and the latest activated segments on LV short-axis images at the apical (RSTa), at the mitral annulus (RSTb), and at the papillary muscle (RSTm) level. RESULTS: The effective rate of LV dyssynchrony improvement was significantly higher in the CABG + BMMNC than in the CABG only group (RSTb: 91.7% vs 50%, P < .05; RSTm: 78.6% vs 35.7%, P < .05; RSTa: 92.3% vs 50%, P < .05). The deterioration rate of LV synchrony was significantly lower in the CABG + BMMNC than in the CABG only group for RSTb (8.3% vs 70%, P < .05;) and RSTm (0 vs 50%, P < .05), but not for RSTa (18.2% vs 37.5%, P > .05). CONCLUSIONS: Combining CABG with BMMNC delivering provided a better improvement of left ventricular dyssynchrony than CABG only.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2018) conducted a meta-analysis in Ischemic heart disease (n=914). CABG combined with bone marrow stem cell (BMSC) transplantation vs. CABG alone was evaluated on Change in left ventricular ejection fraction (LVEF) from baseline to follow-up (MD 3.87%, 95% CI 1.93 to 5.80%, p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: